bromfenac (Duract, Xibrom)
Jump to navigation
Jump to search
Introduction
Tradenames: Duract. FDA approved in 1997. Withdrawn from US market in 1998[2]. Ophthalmic agent: (Xibrom), FDA approved 2005
Indications
post-operative inflammation & eye pain
Dosage
25 mg PO every 6-8 hours for no more than 10 days
Tabs: 25 mg
Adverse effects
* reason for US market withdrawal
More general terms
References
- ↑ Tarascon Pharmacopoeia, Tarascon Publishing, Loma Linda CA, 1998
- ↑ 2.0 2.1 Fresno Bee, Dec. 2000
- ↑ Prescriber's Letter 13(2): 2006 Detail-Document#: http://prescribersletter.com/(5bhgn1a4ni4cyp2tvybwfh55)/pl/ArticleDD.aspx?li=1&st=1&cs=&s=PRL&pt=3&fpt=25&dd=220215&pb=PRL (subscription needed) http://www.prescribersletter.com